| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/26/2001 | EP1135516A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 09/26/2001 | EP1135515A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 09/26/2001 | EP1135513A1 Adenovirus-mediated gene therapy |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135505A1 Therapeutic agents comprising an e3 ubiquitin ligase for use in degenerative disorders |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135488A1 Human semaphorin 6a-1 (sema6a-1), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135482A1 Cancer cell vaccine |
| 09/26/2001 | EP1135481A1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 09/26/2001 | EP1135469A1 An improved method for the production and purification of adenoviral vectors |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135149A1 Pgc-1, a novel brown fat ppar gamma coactivator |
| 09/26/2001 | EP1135113A1 Treatment of parkinson's disease with oligonucleotides |
| 09/26/2001 | EP1135022A1 Plastin promoter directed gene therapy |
| 09/26/2001 | EP0912239B1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | CN1314949A (-)-strand RNA virus vector for nerce cell |
| 09/26/2001 | CN1314948A Targeted adenovirus vectors for delivery of heterologous genes |
| 09/26/2001 | CN1314942A Newcastle disease virus infection clones, vaccine and diagnostic assays |
| 09/25/2001 | US6294663 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294652 Response regulator |
| 09/25/2001 | US6294384 Compositions and methods based upon an isoform of p53 |
| 09/25/2001 | US6294379 Efficient AAV vectors |
| 09/25/2001 | US6294378 Method and reagents for genetic immunization |
| 09/25/2001 | US6294377 Adenoviral vectors of canine origin |
| 09/25/2001 | US6294364 Polynucleotide which codes enzymaatic polypeptide; for the treatment of cancers and bacterial infections |
| 09/25/2001 | US6294357 Nucleotide sequence coding polypeptide for the detection of nucleotide sequences of microorganisms; for prevention of microorganism infections; bactericides |
| 09/25/2001 | US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction |
| 09/25/2001 | US6294346 Preparing cell culture of neurospheres comprising cluster of neural stem cells, contacting with agent, and determining effect on proliferation, differentiation or survival; treatment of nervous system disorders |
| 09/25/2001 | US6294344 Detecting tumor of urogenetial system in humans; obtain sample of human tissue, detect chymotrypsin enzyme in sample, the presence of amplified expression of chymotrypsin is indictive of tumor |
| 09/25/2001 | US6294332 Composition and methods for modulating the length of telomeres |
| 09/25/2001 | US6294175 Compounds |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | US6294165 Vectors and their use in gene transfer. based on retroviruses, adapted so that they cannot package their own rna, and which can be used as infectious agents to transfer foreign genes, e.g. for somatic gene therapy. |
| 09/24/2001 | WO2003006652A2 Inhibition of specific histone deacetylase isoforms |
| 09/24/2001 | CA2408385A1 Inhibition of specific histone deacetylase isoforms |
| 09/20/2001 | WO2001068912A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 09/20/2001 | WO2001068911A2 Diagnosis of diseases associated with the cell cycle |
| 09/20/2001 | WO2001068889A2 Method for gene transfection and vaccination through skin using electropermeabilization |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068879A2 Human 1-aminocyclopropane-carboxylate synthase |
| 09/20/2001 | WO2001068866A2 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use |
| 09/20/2001 | WO2001068856A2 Human transcription factor-like protein and nucleic acids encoding same |
| 09/20/2001 | WO2001068855A2 Gtp-binding protein gamma-12 subunit |
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068850A2 Akt nucleic acids, polypeptides, and uses thereof |
| 09/20/2001 | WO2001068837A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | WO2001068832A1 Method of cleaving single-stranded rna and kit |
| 09/20/2001 | WO2001068828A2 Compositions and methods for regulated protein expression in gut |
| 09/20/2001 | WO2001068825A1 Human nim1 kinase |
| 09/20/2001 | WO2001068822A2 Method of treating phenylketonuria and means therefor |
| 09/20/2001 | WO2001068820A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 09/20/2001 | WO2001068815A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068697A2 Methods and compositions for immunoregulation |
| 09/20/2001 | WO2001068665A1 Human histamine h3 gene variant-1 |
| 09/20/2001 | WO2001068148A1 Systemic gene delivery vehicles for the treatment of tumors |
| 09/20/2001 | WO2001068147A2 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 09/20/2001 | WO2001068146A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/20/2001 | WO2001068144A2 Biodegradable immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068143A2 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | WO2001068135A2 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | WO2001068131A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 09/20/2001 | WO2001068122A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001068116A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 09/20/2001 | WO2001068108A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 09/20/2001 | WO2001068093A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
| 09/20/2001 | WO2001068078A2 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | WO2001067862A1 Adrenergic receptor overexpression in airway tissues for the treatment of airway obstructive diseases |
| 09/20/2001 | WO2001019851A3 Opaminergic neuronal survival-promoting factors and uses thereof |
| 09/20/2001 | WO2001016317A3 Polycyclic aromatic hydrocarbon induced molecules |
| 09/20/2001 | WO2001016167A3 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014581A3 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/20/2001 | WO2001008702A9 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 09/20/2001 | WO2001007065B1 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 09/20/2001 | WO2001002540A9 Adenoviral vectors for treating disease |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | WO2000044774A9 Inhibition of stat3 signal transduction for human cancer therapy |
| 09/20/2001 | US20010023349 Hypodermic needle with weeping tip and method of use |
| 09/20/2001 | US20010023242 Polypeptide from snake venom |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403205A1 Compositions and methods of regulated protein expression in gut endocrine k cells |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2403000A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | CA2402530A1 Blocking leukocyte emigration and inflammation by interfering with cd99 |
| 09/20/2001 | CA2402413A1 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | CA2402294A1 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | CA2402265A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |